Inbrija 42 mg/1 (Levodopa CAPSULE) 42 mg/1

Inbrija 42 mg/1 is an inhalation capsule designed to deliver levodopa for respiratory administration. It is commonly used for the treatment of Parkinson's disease symptoms, offering a convenient and effective solution for managing motor fluctuations. This product is manufactured by Merz Pharmaceuticals, LLC.

Strength

42 mg/1

Pack Size

8 BLISTER PACK in 1 CARTON (10144-342-32) / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)

Manufacturer / TM Owner

Merz Pharmaceuticals, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Inbrija 42 mg/1 is primarily used for the management of Parkinson's disease symptoms, particularly motor fluctuations. It is designed to provide quick relief from symptoms such as tremors, stiffness, and difficulty moving. This medication is intended for use in adults who experience off episodes, which are periods when Parkinson's symptoms return between doses of their regular medication. Inbrija is administered via inhalation, making it a unique option for those who prefer this method of delivery.

Side Effects

Common effects of Inbrija 42 mg/1 may include improved mobility and reduced symptoms of Parkinson's disease. Users may experience quicker relief from motor fluctuations compared to oral medications. However, individual responses can vary, and it is important to monitor for any adverse reactions. Some users may also experience temporary side effects such as cough or throat irritation due to the inhalation method.

Precautions & Warnings

Inbrija 42 mg/1 should be used with caution, especially by individuals with respiratory conditions. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Users should avoid smoking or using other inhalants during treatment. Additionally, those with a history of heart disease or high blood pressure should consult their healthcare provider before using this medication.

Avoid Interactions

Inbrija 42 mg/1 may interact with other medications, including those that affect the central nervous system. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also interact with Inbrija, so it is advisable to discuss dietary and lifestyle habits with your healthcare provider. Always follow the guidance of a healthcare professional to minimize the risk of interactions.

Frequently Asked Questions

Inbrija 42 mg/1 is used to manage motor fluctuations in Parkinson's disease, providing relief from symptoms such as tremors and stiffness.

Inbrija 42 mg/1 is administered via inhalation using a specialized inhaler device.

Common side effects may include cough, throat irritation, and temporary worsening of Parkinson's symptoms.

Inbrija 42 mg/1 may be used in conjunction with other Parkinson's medications, but it is important to consult a healthcare provider for personalized advice.

Inbrija 42 mg/1 is designed for adults experiencing off episodes, but suitability varies; consult a healthcare provider for individualized recommendations.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.